Loading clinical trials...
Loading clinical trials...
A Double Masked, Placebo Controlled, Randomised, Parallel Group Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-Ocular Pressure
Conditions
Interventions
AZD4017
Placebo
+2 more
Locations
11
United States
Research Site
Newport Beach, California, United States
Research Site
Atlanta, Georgia, United States
Research Site
Morrow, Georgia, United States
Research Site
Overland Park, Kansas, United States
Research Site
Charlotte, North Carolina, United States
Research Site
Durham, North Carolina, United States
Start Date
December 1, 2010
Primary Completion Date
November 1, 2012
Completion Date
November 1, 2012
Last Updated
February 14, 2014
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions